Literature DB >> 15699460

14,15-epoxyeicosatrienoic acid represents a transferable endothelium-dependent relaxing factor in bovine coronary arteries.

Kathryn M Gauthier1, Erik M Edwards, John R Falck, Dendi S Reddy, William B Campbell.   

Abstract

Bradykinin causes arterial relaxation and hyperpolarization, which is mediated by a transferable endothelium-derived hyperpolarizing factor (EDHF). In coronary arteries, epoxyeicosatrienoic acids (EETs) are involved in the EDHF response. However, the role of EETs as transferable mediators of EDHF-dependent relaxation remains poorly defined. Two small bovine coronary arteries were cannulated and perfused in tandem in the presence of the nitric oxide synthase inhibitor, nitro-L-arginine (30 micromol/L), and the cyclooxygenase inhibitor, indomethacin (10 micromol/L). Luminal perfusate from donor arteries with intact endothelium perfused endothelium-denuded detector arteries. Detector arteries were constricted with U46619 and diameters were monitored. Bradykinin (10 nmol/L) added to detector arteries did not induce dilation (5+/-2%), whereas bradykinin addition to donor arteries dilated detector arteries by 26.5+/-7% (P<0.05). These dilations were blocked by donor artery endothelium removal and detector artery treatment with the EET-selective antagonist, 14,15-epoxyeicosa-5(Z)-monoenoic acid (14,15-EEZE; 10 micromol/L, -5+/-6%) but not 14,15-EEZE treatment of donor arteries (20+/-5%). 14,15-EET (0.1 to 10 micromol/L) added to detector arteries induced maximal dilations of 82+/-5% that were inhibited 50% by detector artery treatment with 14,15-EEZE (32+/-12%) but not donor artery treatment with 14,15-EEZE. Liquid chromatography-electrospray ionization mass spectrometry analysis verified the presence of 14,15-EET in the perfusate from an endothelium-intact but not denuded artery. These results show that bradykinin stimulates donor artery 14,15-EET release that dilates detector arteries. 14,15-EEZE blocked the donor artery, endothelium-dependent, bradykinin-induced relaxations, and attenuated relaxations to 14,15-EET. These results suggest that EETs are transferable EDHFs in coronary arteries.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15699460     DOI: 10.1161/01.HYP.0000153462.06604.5d

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  28 in total

1.  Role of ω-hydroxylase in adenosine-mediated aortic response through MAP kinase using A2A-receptor knockout mice.

Authors:  Dovenia S Ponnoth; Mohammed A Nayeem; Swati S Kunduri; Stephen L Tilley; Darryl C Zeldin; Catherine Ledent; S Jamal Mustafa
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-07       Impact factor: 3.619

Review 2.  Connexins and gap junctions in the EDHF phenomenon and conducted vasomotor responses.

Authors:  Cor de Wit; Tudor M Griffith
Journal:  Pflugers Arch       Date:  2010-04-09       Impact factor: 3.657

Review 3.  Calcium-activated potassium channels and endothelial dysfunction: therapeutic options?

Authors:  Michel Félétou
Journal:  Br J Pharmacol       Date:  2009-01-29       Impact factor: 8.739

4.  Role of CYP epoxygenases in A2A AR-mediated relaxation using A2A AR-null and wild-type mice.

Authors:  Mohammed A Nayeem; Samuel M Poloyac; John R Falck; Darryl C Zeldin; Catherine Ledent; Dovenia S Ponnoth; Habib R Ansari; S Jamal Mustafa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-09-19       Impact factor: 4.733

Review 5.  Soluble epoxide hydrolase inhibitors and heart failure.

Authors:  Hong Qiu; Ning Li; Jun-Yan Liu; Todd R Harris; Bruce D Hammock; Nipavan Chiamvimonvat
Journal:  Cardiovasc Ther       Date:  2011-04       Impact factor: 3.023

6.  Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition.

Authors:  Brandon T Larsen; Hiroto Miura; Ossama A Hatoum; William B Campbell; Bruce D Hammock; Darryl C Zeldin; John R Falck; David D Gutterman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-10-28       Impact factor: 4.733

7.  Melanopsin mediates light-dependent relaxation in blood vessels.

Authors:  Gautam Sikka; G Patrick Hussmann; Deepesh Pandey; Suyi Cao; Daijiro Hori; Jong Taek Park; Jochen Steppan; Jae Hyung Kim; Viachaslau Barodka; Allen C Myers; Lakshmi Santhanam; Daniel Nyhan; Marc K Halushka; Raymond C Koehler; Solomon H Snyder; Larissa A Shimoda; Dan E Berkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-17       Impact factor: 11.205

8.  Endothelium-derived hyperpolarizing factor mediates bradykinin-stimulated tissue plasminogen activator release in humans.

Authors:  Ayaz M Rahman; Jonathan R Murrow; Muhiddin A Ozkor; Nino Kavtaradze; Ji Lin; Christine De Staercke; W Craig Hooper; Amita Manatunga; Salim Hayek; Arshed A Quyyumi
Journal:  J Vasc Res       Date:  2014-06-04       Impact factor: 1.934

Review 9.  Lung Circulation.

Authors:  Karthik Suresh; Larissa A Shimoda
Journal:  Compr Physiol       Date:  2016-03-15       Impact factor: 9.090

10.  Epoxyeicosatrienoic acid analogue mitigates kidney injury in a rat model of radiation nephropathy.

Authors:  Md Abdul Hye Khan; Brian Fish; Geneva Wahl; Amit Sharma; John R Falck; Mahesh P Paudyal; John E Moulder; John D Imig; Eric P Cohen
Journal:  Clin Sci (Lond)       Date:  2016-01-15       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.